These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 4761552)

  • 21. The release of endogenous norepinephrine and dopamine from cerebral cortex by amphetamine.
    Arnold EB; Molinoff PB; Rutledge CO
    J Pharmacol Exp Ther; 1977 Sep; 202(3):544-57. PubMed ID: 894521
    [No Abstract]   [Full Text] [Related]  

  • 22. Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates.
    Snyder SH; Coyle JT
    J Pharmacol Exp Ther; 1969 Jan; 165(1):78-86. PubMed ID: 5782836
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of the uptake of 5-hydroxytryptamine, noradrenaline and dopamine into rat brain homogenates by various hydroxylated tryptamines.
    Horn AS; Baumgarten HG; Schlosserberger HG
    J Neurochem; 1973 Jul; 21(1):233-6. PubMed ID: 4720899
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of amphetamines on the metabolism of catecholamines in the rat brain.
    Baldessarini RJ; Harris JE
    J Psychiatr Res; 1974; 11():41-3. PubMed ID: 4477777
    [No Abstract]   [Full Text] [Related]  

  • 25. Release of dopamine from central noradrenaline nerves after treatment with reserpine plus amphetamine.
    Andén NE; Svensson TH
    J Neural Transm; 1973; 34(1):23-30. PubMed ID: 4714591
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of the effects of amphetamine and its metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine, on uptake, release and catabolism of 3H-norepinephrine in cerebral cortex of rat brain.
    Wenger GR; Rutledge CO
    J Pharmacol Exp Ther; 1974 Jun; 189(3):725-32. PubMed ID: 4152317
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of (+)-amphetamine on the retention of 3H-catecholamines in slices of normal and reserpinized rat brain and heart.
    Ross SB; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):328-36. PubMed ID: 581027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specificity of release of biogenic amines from isolated rat brain tissue as a function of the meta substituent of N-ethylamphetamine derivatives.
    Tessel RE; Rutledge CO
    J Pharmacol Exp Ther; 1976 May; 197(2):253-62. PubMed ID: 1271279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible circadian and seasonal rhythmicity in an in vitro model: monoamine uptake in rat brain slices.
    Wirz-Justice A
    Experientia; 1974 Nov; 30(11):1240-1. PubMed ID: 4474089
    [No Abstract]   [Full Text] [Related]  

  • 30. Levels of dopamine, norepinephrine and 5-hydroxytryptamine in different regions of the rat brain in thallium toxicosis.
    Hasan M; Ali SF; Tariq M
    Acta Pharmacol Toxicol (Copenh); 1978 Sep; 43(3):169-73. PubMed ID: 707129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphine effects on the levels and turnover of catecholamines in rat brain.
    Johnson JC; Ratner M; Gold CJ; Clouet DH
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):41-53. PubMed ID: 4438827
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of amphetamine on brain biogenic amines in isolated and aggregated rats.
    Lokiec F; Jacquot C; Rapin JR; Cohen Y
    Eur J Pharmacol; 1977 Aug; 44(4):391-5. PubMed ID: 891613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of delta9-tetrahydrocannabinol on brain amine concentration and turnover in whole rat brain and in various regions of the brain.
    Bracs P; Jackson DM; Chesher GB
    J Pharm Pharmacol; 1975 Sep; 27(9):713-5. PubMed ID: 241821
    [No Abstract]   [Full Text] [Related]  

  • 34. Central supersensitivity to norepinephrine and amphetamine following brain chemical sympathectomy by 6-hydroxydopamine.
    Blum K; Wallace JE; Schwertner HA; Meyer E; Morgan WW
    Life Sci; 1977 May; 20(10):1705-13. PubMed ID: 875616
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat.
    Baldessarini RJ; Lipinski JF; Chace KV
    Biochem Pharmacol; 1972 Jan; 21(1):77-87. PubMed ID: 5058704
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta.
    Ferris RM; Tang FL; Maxwell RA
    J Pharmacol Exp Ther; 1972 Jun; 181(3):407-16. PubMed ID: 5033010
    [No Abstract]   [Full Text] [Related]  

  • 37. A simple and rapid method for injecting H3-norepinephrine into the lateral ventricle of the rat brain.
    Noble EP; Wurtman RJ; Axelrod J
    Life Sci; 1967 Feb; 6(3):281-91. PubMed ID: 6071872
    [No Abstract]   [Full Text] [Related]  

  • 38. Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues.
    Harris JE; Baldessarini RJ
    Neuropharmacology; 1973 Jul; 12(7):669-79. PubMed ID: 4730376
    [No Abstract]   [Full Text] [Related]  

  • 39. Selective (+)-amphetamine neurotoxicity on striatal dopamine nerve terminals in the mouse.
    Jonsson G; Nwanze E
    Br J Pharmacol; 1982 Oct; 77(2):335-45. PubMed ID: 7139192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of morphine and pentazocine on the turnover of noradrenaline and dopamine in various regions of the rat brain.
    Sugrue MF
    Br J Pharmacol; 1973 Mar; 47(3):644P. PubMed ID: 4730858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.